IGF-2 and FLT-1/VEGF-R1 mRNA Levels Reveal Distinctions and Similarities Between Congenital and Common Infantile Hemangioma
Open Access
- 1 March 2008
- journal article
- research article
- Published by Springer Nature in Pediatric Research
- Vol. 63 (3) , 263-267
Abstract
Common infantile hemangioma appears postnatally, grows rapidly, and regresses slowly. Two types of congenital vascular tumors present fully grown at birth and behave differently from infantile hemangioma. These rare congenital tumors have been designated rapidly involuting congenital hemangioma (RICH) and noninvoluting congenital hemangioma (NICH). RICH and NICH are similar in appearance, location, and size, and have some overlapping histologic features with infantile hemangioma. At a molecular level, neither expresses glucose transporter-1, a diagnostic marker of infantile hemangioma. To gain further insight into the molecular differences and similarities between congenital and common hemangioma, we analyzed expression of insulin-like growth factor-2, known to be highly expressed in infantile hemangioma and VEGF-receptors, by quantitative real-time PCR, in three RICH and five NICH specimens. We show that insulin-like growth factor-2 mRNA was expressed in both RICH and NICH, at a level comparable with that detected in common hemangioma over 4 y of age. In contrast, mRNA levels for membrane-associated fms-like tyrosine-kinase receptor, also known as VEGF receptor-1, were uniformly increased in congenital hemangiomas compared with proliferating or involuting phase common hemangioma. These results provide the first evidence of the molecular distinctions and similarities between congenital and postnatal hemangioma.Keywords
This publication has 13 references indexed in Scilit:
- Rapidly Involuting Congenital Hemangioma: Clinical and Histopathologic FeaturesPediatric and Developmental Pathology, 2003
- Gene quantification using real-time quantitative PCRExperimental Hematology, 2002
- Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysisProceedings of the National Academy of Sciences, 2002
- Noninvoluting Congenital Hemangioma: A Rare Cutaneous Vascular AnomalyPlastic and Reconstructive Surgery, 2001
- Regulation of glut1 mRNA by Hypoxia-inducible Factor-1Journal of Biological Chemistry, 2001
- Neuropilin-2 and Neuropilin-1 Are Receptors for the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF) and of Placenta Growth Factor-2, but Only Neuropilin-2 Functions as a Receptor for the 145-Amino Acid Form of VEGFJournal of Biological Chemistry, 2000
- GLUT1: A newly discovered immunohistochemical marker for juvenile hemangiomasHuman Pathology, 2000
- Flt-1, a receptor for vascular endothelial growth factor, has transforming and morphogenic potentialsOncogene, 1998
- Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth FactorCell, 1998
- Congenital hemangioma: Evidence of accelerated involutionThe Journal of Pediatrics, 1996